Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, USA.
J Am Med Inform Assoc. 2023 Nov 17;30(12):2036-2040. doi: 10.1093/jamia/ocad134.
Despite recent methodology advancements in clinical natural language processing (NLP), the adoption of clinical NLP models within the translational research community remains hindered by process heterogeneity and human factor variations. Concurrently, these factors also dramatically increase the difficulty in developing NLP models in multi-site settings, which is necessary for algorithm robustness and generalizability. Here, we reported on our experience developing an NLP solution for Coronavirus Disease 2019 (COVID-19) signs and symptom extraction in an open NLP framework from a subset of sites participating in the National COVID Cohort (N3C). We then empirically highlight the benefits of multi-site data for both symbolic and statistical methods, as well as highlight the need for federated annotation and evaluation to resolve several pitfalls encountered in the course of these efforts.
尽管临床自然语言处理 (NLP) 在方法学上取得了新的进展,但在转化研究领域,临床 NLP 模型的采用仍然受到过程异质性和人为因素变化的阻碍。同时,这些因素也极大地增加了在多站点环境中开发 NLP 模型的难度,这对于算法的稳健性和通用性是必要的。在这里,我们报告了在一个开放的 NLP 框架中,从参与国家 COVID 队列 (N3C) 的一部分站点中,为 2019 年冠状病毒病 (COVID-19) 症状和体征提取开发 NLP 解决方案的经验。然后,我们实证强调了多站点数据对符号和统计方法的好处,并强调需要联邦注释和评估来解决这些努力过程中遇到的几个陷阱。